Microbiology and Immunology
Agencies dhwani
EUFETS_CompanyPresentationDEC14
37168
16 th Annual NIH SBIR/STTR Conference Functional Down-to-Earth Advice for understanding the FDA Chris Sasiela, PhD, RAC NHLBI Office of Translational Alliances.
FDA Oversight of Cell Therapy Clinical Trials Celia Witten, Ph.D., M.D. Office Director, Office of Cellular, Tissue, and Gene Therapies CBER/FDA ISSCR/CIRM/ISCT.
European Parliament Advanced Therapies Hearing May 11, 2006 Advanced Therapies The proposed EU regulation from the viewpoint of a Pharmaceutical company.
OCTGT Guidance Document Update
Deborah Hursh, Ph.D. Office of Cellular, Tissue, and Gene Therapies
Innovation Through Collaboration: Why the CSS Working Groups are Important to the FDA Steve Wilson, DrPH, CAPT USPHS Director, FDA/CDER/OTS/OB/DBIII 2014.
The FDA Review Process
Cellular and Gene Therapies for Retinal Disorders Samuel B. Barone, M.D. Office of Cellular, Tissue, and Gene Therapies Center for Biologics Evaluation.
